돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 43619생성일: 2026년 10월 24일

Ethyl 2-chloroacetoacetate → Ethyl cis(+/-)-2-(4-{[(benzyloxy)carbonyl]amino}-3-methoxypiperidin-1-yl)-4-methyl-1,3-oxazole-5-carboxylate

https://huagongshe.com/ko/reaction/43619

반응식

참여 물질

역할이름HCID투입량
반응물Ethyl 2-chloroacetoacetateHCID 11858—
반응물Sodium BicarbonateHCID 516892—
반응물cis(+/-)-Benzyl (1-carbamoyl-3-methoxypiperidin-4-yl)carbamateHCID 131730860—
용매Ethyl AcetateHCID 8857—
생성물Ethyl cis(+/-)-2-(4-{[(benzyloxy)carbonyl]amino}-3-methoxypiperidin-1-yl)-4-methyl-1,3-oxazole-5-carboxylateHCID 8664858631.1%

반응 단계

cis(±)-Benzyl (1-carbamoyl-3-methoxypiperidin-4-yl)carbamate obtained in Example (103b) (0.92 g, 3 mmol), ethyl α-chloroacetoacetate (3.29 g, 20 mmol) and sodium bicarbonate (0.84 g, 10 mmol) were stirred at 120° C. for three hours. The reaction solution was diluted with ethyl acetate, washed with water and brine, and dried over anhydrous magnesium sulfate. Following concentration under reduced pressure, the residue was purified by silica gel column chromatography (elution solvent: ethyl acetate/hexane=1/4, 1/2, 2/1, 4/1) to obtain 0.39 g of the title compound as a light brown solid (27%).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08536197B2
출처 데이터셋uspto-grants-2013_09
ORD IDord-30f44b51507f4bd78b3a48bf8acb5563
출처 메모uspto-grants-2013_09